阿佩利斯制药公司
US ˙ NasdaqGS ˙ US03753U1060

介绍

本页面提供了有关 Watson David O. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Watson David O.已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:APLS / Apellis Pharmaceuticals, Inc. General Counsel 50,136
如何解读这些图表

以下图表显示了在Watson David O.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

APLS / Apellis Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
APLS / Apellis Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2025-09-10 APLS Watson David O. 20,000 26.1700 20,000 26.1700 523,400 2 24.8500 -26,400 -5.04
2025-03-05 APLS Watson David O. 5,569 25.1013 5,569 25.1013 139,789
2025-01-29 APLS Watson David O. 695 29.5236 695 29.5236 20,519
2025-01-22 APLS Watson David O. 3,323 30.4255 3,323 30.4255 101,104
2025-01-17 APLS Watson David O. 2,201 29.9582 2,201 29.9582 65,938
2025-01-13 APLS Watson David O. 4,965 28.7021 4,965 28.7021 142,506
2024-12-11 APLS Watson David O. 5,000 34.2350 5,000 34.2350 171,175
2024-02-12 APLS Watson David O. 781 67.7669 781 67.7669 52,926
2024-01-29 APLS Watson David O. 906 64.1382 906 64.1382 58,109
2024-01-22 APLS Watson David O. 4,184 64.9960 4,184 64.9960 271,943
2024-01-16 APLS Watson David O. 4,240 66.8086 4,240 66.8086 283,268
2023-12-19 APLS Watson David O. 1,605 57.0041 1,605 57.0041 91,492
2023-12-19 APLS Watson David O. 2,300 57.3827 2,300 57.3827 131,980
2022-06-22 APLS Watson David O. 10,000 44.5140 10,000 44.5140 445,140
2021-12-27 APLS Watson David O. 1,200 48.5000 1,200 48.5000 58,200
2021-12-22 APLS Watson David O. 5,174 47.7160 5,174 47.7160 246,883
2021-12-22 APLS Watson David O. 5,097 47.8550 5,097 47.8550 243,917
2021-12-22 APLS Watson David O. 300 48.5770 300 48.5770 14,573
2020-12-14 APLS Watson David O. 2,709 50.6070 2,709 50.6070 137,094
2020-12-14 APLS Watson David O. 2,526 51.3160 2,526 51.3160 129,624
2020-12-14 APLS Watson David O. 1,163 52.7270 1,163 52.7270 61,322
2020-12-14 APLS Watson David O. 900 53.8610 900 53.8610 48,475
2020-12-14 APLS Watson David O. 900 55.0010 900 55.0010 49,501
2020-12-14 APLS Watson David O. 200 55.9080 200 55.9080 11,182
2020-12-11 APLS Watson David O. 9,935 50.0000 9,935 50.0000 496,750
2018-09-14 APLS Watson David O. 15,776 18.7840 15,776 18.7840 296,336

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
内幕交易历史

该表格显示了由 Watson David O. 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2025-09-12 2025-09-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -20,000 50,136 -28.52 26.17 -523,400 1,312,059
2025-08-19 2025-08-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,000 123,730 -3.88 27.80 -139,000 3,439,694
2025-07-18 2025-07-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,000 128,730 -3.74 19.55 -97,750 2,516,672
2025-06-18 2025-06-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,000 133,730 -3.60 18.77 -93,850 2,510,112
2025-03-06 2025-03-05 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,569 138,730 -3.86 25.10 -139,789 3,482,303
2025-03-06 2025-03-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift 6,667 10,000 200.03
2025-03-06 2025-03-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -6,667 0 -100.00
2025-01-30 2025-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -695 144,299 -0.48 29.52 -20,519 4,260,226
2025-01-23 2025-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -3,323 144,994 -2.24 30.43 -101,104 4,411,515
2025-01-21 2025-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 42,762 148,317 40.51
2025-01-21 2025-01-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,201 105,555 -2.04 29.96 -65,938 3,162,238
2025-01-14 2025-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -4,965 107,756 -4.40 28.70 -142,506 3,092,823
2024-12-13 2024-12-11 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,000 112,721 -4.25 34.24 -171,175 3,859,003
2024-09-30 2024-09-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift 10,569 117,721 9.86
2024-09-30 2024-09-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -10,569 70,136 -13.10
2024-03-08 2024-03-06 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 3,762 107,152 3.64 13.85 52,104 1,484,055
2024-02-13 2024-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -781 103,390 -0.75 67.77 -52,926 7,006,420
2024-01-31 2024-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -906 104,171 -0.86 64.14 -58,109 6,681,340
2024-01-23 2024-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -4,184 105,077 -3.83 65.00 -271,943 6,829,585
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -4,240 109,261 -3.74 66.81 -283,268 7,299,574
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 23,748 113,501 26.46
2023-12-20 2023-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,300 89,753 -2.50 57.38 -131,980 5,150,269
2023-12-20 2023-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,605 92,053 -1.71 57.00 -91,492 5,247,398
2023-12-20 2023-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 7,905 93,658 9.22 13.85 109,484 1,297,163
2023-07-06 2023-07-03 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -8,510 85,753 -9.03 89.98 -765,730 7,716,055
2023-06-29 2023-06-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift 12,750 80,705 18.76
2023-06-29 2023-06-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -12,750 94,263 -11.91
2023-04-24 2023-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift 67,955 67,955
2023-04-24 2023-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -67,955 107,013 -38.84
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -825 174,968 -0.47 58.50 -48,262 10,235,628
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 9,886 175,793 5.96
2023-02-14 2023-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -532 165,907 -0.32 51.21 -27,244 8,496,097
2023-01-30 2023-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -551 166,439 -0.33 52.77 -29,076 8,782,986
2023-01-24 2023-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -2,034 166,990 -1.20 52.05 -105,870 8,691,830
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 29,452 169,024 21.10
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 24,003 139,572 20.77
2022-06-23 2022-06-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,000 115,569 -7.96 44.51 -445,140 5,144,438
2022-04-27 2022-04-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,000 125,569 -3.83 50.00 -250,000 6,278,450
2022-04-27 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		J - Other -11,250 0 -100.00
2022-04-27 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		J - Other -1,875 130,569 -1.42
2022-02-14 2022-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -491 132,444 -0.37 47.12 -23,136 6,240,761
2022-02-10 2021-12-08 5 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -3,333 3,333 -50.00
2022-02-01 2022-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -650 132,935 -0.49 38.59 -25,084 5,129,962
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 36,951 36,951
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 26,051 133,585 24.23
2021-12-28 2021-12-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,200 107,534 -1.10 48.50 -58,200 5,215,399
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -5,397 14,888 -26.61
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -4,715 20,285 -18.86
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -4,826 11,667 -29.26
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -5,174 16,493 -23.88
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -300 108,734 -0.28 48.58 -14,573 5,281,972
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,097 109,034 -4.47 47.86 -243,917 5,217,822
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 5,397 114,131 4.96 14.95 80,685 1,706,258
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 4,715 108,734 4.53 14.95 70,489 1,625,573
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,174 104,019 -4.74 47.72 -246,883 4,963,371
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 4,826 109,193 4.62 13.85 66,840 1,512,323
2021-12-23 2021-12-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 5,174 104,367 5.22 13.85 71,660 1,445,483
2021-09-13 2021-09-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -954 0 -100.00
2021-09-13 2021-09-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 954 99,193 0.97 4.31 4,112 427,522
2021-06-22 2021-06-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -489 954 -33.89
2021-06-22 2021-06-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 489 98,239 0.50 4.31 2,108 423,410
2021-06-01 2021-05-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -489 1,443 -25.31
2021-06-01 2021-05-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 489 97,750 0.50 4.31 2,108 421,302
2021-04-23 2021-04-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -489 1,932 -20.20
2021-04-23 2021-04-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 489 97,261 0.51 4.31 2,108 419,195
2021-03-23 2021-03-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -978 2,421 -28.77
2021-03-23 2021-03-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 978 96,772 1.02 4.31 4,215 417,087
2021-02-11 2021-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		F - Taxes -468 95,794 -0.49 47.72 -22,333 4,571,290
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 11,250 11,250
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 45,000 45,000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 1,875 96,262 1.99
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 7,500 94,387 8.63
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -20,042 3,399 -85.50
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -23,441 0 -100.00
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 20,042 86,887 29.98 4.31 86,381 374,483
2021-01-29 2021-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 23,441 66,845 54.01 3.76 88,138 251,337
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -8,398 21,667 -27.93
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -200 43,404 -0.46 55.91 -11,182 2,426,631
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -900 43,604 -2.02 55.00 -49,501 2,398,264
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -900 44,504 -1.98 53.86 -48,475 2,397,030
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,163 45,404 -2.50 52.73 -61,322 2,394,017
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,526 46,567 -5.15 51.32 -129,624 2,389,632
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,709 49,093 -5.23 50.61 -137,094 2,484,449
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 8,398 51,802 19.35 13.85 116,312 717,458
2020-12-15 2020-12-11 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -9,935 30,065 -24.84
2020-12-15 2020-12-11 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -9,935 43,404 -18.63 50.00 -496,750 2,170,200
2020-12-15 2020-12-11 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 9,935 53,339 22.89 13.85 137,600 738,745
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy) 		M - Exercise -7,505 0 -100.00
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy) 		A - Award 38,250 38,250
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 7,505 42,922 21.19 2.67 20,038 114,602
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -5,000 35,417 -12.37 44.50 -222,500 1,576,056
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 6,375 40,417 18.73
2020-01-28 2020-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -15,000 7,505 -66.65
2020-01-28 2020-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 15,000 34,042 78.77 2.67 40,050 90,892
2020-01-28 2020-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,000 19,042 -13.61 40.47 -121,401 770,573
2019-08-09 2019-08-07 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -5,000 22,505 -18.18
2019-08-09 2019-08-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 5,000 22,042 29.34 2.67 13,350 58,852
2019-02-12 2019-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy) 		A - Award 40,000 40,000
2018-09-17 2018-09-14 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -32,818 27,505 -54.40
2018-09-17 2018-09-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -15,776 17,042 -48.07 18.78 -296,336 320,117
2018-09-17 2018-09-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 32,818 32,818 2.67 87,624 87,624
2018-05-30 2018-05-29 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -624 60,323 -1.02
2018-05-30 2018-05-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		G - Gift -624 0 -100.00
2018-05-30 2018-05-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 624 624 2.67 1,666 1,666
2018-02-21 2018-02-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 25,000 25,000
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		18,752
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		18,752
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）